{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:35:16Z","timestamp":1793914516994,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.tube.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T13:07:45Z","timestamp":1552568865000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin"],"prefix":"10.1016","volume":"115","author":[{"given":"Yesha S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishita","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3844-4726","authenticated-orcid":false,"given":"Sarika","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.03.004_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"139","key":"10.1016\/j.tube.2019.03.004_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1183\/16000617.0085-2015","article-title":"The role of moxifloxacin in tuberculosis therapy","volume":"25","author":"Gillespie","year":"2016","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"issue":"6","key":"10.1016\/j.tube.2019.03.004_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/40.6.797","article-title":"Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin","volume":"40","author":"Klugman","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2019.03.004_bib4","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3389\/fmicb.2017.02075","article-title":"Synergistic response of rifampicin with hydroperoxides on Mycobacterium: a mechanistic study","volume":"8","author":"Patel","year":"2017","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2019.03.004_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.apsb.2016.01.008","article-title":"Artemisinin anti-malarial drugs in China","volume":"6","author":"Guo","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.tube.2019.03.004_bib6","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2147\/DDDT.S118116","article-title":"Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold","volume":"10","author":"Rudrapal","year":"2016","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"10.1016\/j.tube.2019.03.004_bib7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkt486","article-title":"Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential","volume":"69","author":"Antoine","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.tube.2019.03.004_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jac\/dkf104","article-title":"Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum","volume":"50","author":"Pradines","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.tube.2019.03.004_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1248\/bpb.23.1275","article-title":"Effect of artemisinin on lipid peroxidation and fluidity of the erythrocyte membrane in malaria","volume":"23","author":"Sibmooh","year":"2000","journal-title":"Biol Pharmaceut Bull"},{"issue":"3","key":"10.1016\/j.tube.2019.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6030030","article-title":"Novel pharmacological activity of artesunate and artemisinin: their potential as anti-tubercular agents","volume":"6","author":"Choi","year":"2017","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.tube.2019.03.004_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio.2259","article-title":"Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence","volume":"13","author":"Zheng","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.tube.2019.03.004_bib12","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/ja109665t","article-title":"Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria","volume":"133","author":"Miller","year":"2011","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.tube.2019.03.004_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01586-16","article-title":"Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application","volume":"8","author":"Kerantzas","year":"2017","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.tube.2019.03.004_bib14","first-page":"796","article-title":"Role of individual drugs in the chemotherapy of tuberculosis","volume":"4","author":"Mitchison","year":"2000","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.tube.2019.03.004_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jac\/dkm207","article-title":"Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis","volume":"60","author":"Taneja","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"27","key":"10.1016\/j.tube.2019.03.004_bib16","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.1074\/jbc.M115.666123","article-title":"Comparative proteomic analyses of avirulent, virulent and clinical strains of Mycobacterium tuberculosis identifies strain-specific patterns","volume":"291","author":"Jhingan","year":"2016","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.tube.2019.03.004_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/AAC.50.3.949-954.2006","article-title":"Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli","volume":"50","author":"Goswami","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2019.03.004_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jac\/dkm117","article-title":"Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay","volume":"60","author":"Jadaun","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.tube.2019.03.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.tube.2019.03.004_bib20","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1128\/AAC.02712-15","article-title":"A flow cytometry method for rapidly assessing Mycobacterium tuberculosis responses to antibiotics with different modes of action","volume":"60","author":"Hendon-Dunn","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.03.004_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tube.2017.04.010","article-title":"The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs","volume":"105","author":"Bax","year":"2017","journal-title":"Tuberculosis"},{"issue":"5","key":"10.1016\/j.tube.2019.03.004_bib22","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.37.5.1108","article-title":"Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)","volume":"37","author":"Meshnick","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.tube.2019.03.004_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jat.2550130409","article-title":"Lipid peroxidation and disintegration of the cell membrane structure in cultures of rat lung fibroblasts treated with asbestos","volume":"13","author":"Hiroshi","year":"1993","journal-title":"J Appl Toxicol"},{"issue":"12","key":"10.1016\/j.tube.2019.03.004_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168098","article-title":"Two-phase bactericidal mechanism of silver nanoparticles against burkholderia pseudomallei","volume":"11","author":"Siritongsuk","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.tube.2019.03.004_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2672.2003.01923.x","article-title":"Membrane damage to bacteria caused by single and combined biocides","volume":"94","author":"Johnston","year":"2003","journal-title":"J Appl Microbiol"},{"issue":"4","key":"10.1016\/j.tube.2019.03.004_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijantimicag.2014.11.017","article-title":"Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis","volume":"45","author":"Gonzaloa","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.tube.2019.03.004_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.lfs.2005.09.004","article-title":"New perspectives on natural products in TB drug research","volume":"78","author":"Pauli","year":"2005","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.tube.2019.03.004_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.60.4.515","article-title":"Biological studies of the tubercle bacillus : iii. Dissociation and pathogenicity of the r and s variants of the human tubercle bacillus (h(37))","volume":"60","author":"Steenken","year":"1934","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.tube.2019.03.004_bib29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"6","key":"10.1016\/j.tube.2019.03.004_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2125.2001.01458.x","article-title":"A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria","volume":"52","author":"Suputtamongkol","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.tube.2019.03.004_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","article-title":"Toxicity of the antimalarial artemisinin and its derivatives","volume":"40","author":"Efferth","year":"2010","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"10.1016\/j.tube.2019.03.004_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.tube.2019.03.004_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2019.03.004_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.012","article-title":"Artemisinin and its derivatives in treating protozoan infections beyond malaria","volume":"117","author":"Loo","year":"2017","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.tube.2019.03.004_bib35","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/np050074u","article-title":"Antifungal activity of artemisinin derivatives","volume":"68","author":"Galal","year":"2005","journal-title":"J Nat Prod"},{"issue":"3","key":"10.1016\/j.tube.2019.03.004_bib36","first-page":"326","article-title":"Combination therapy--a way to forestall artemisinin resistance and optimize uncomplicated malaria treatment","volume":"8","author":"Stefan","year":"2015","journal-title":"J Med Life"},{"issue":"3 Suppl","key":"10.1016\/j.tube.2019.03.004_bib37","first-page":"13","article-title":"Artemisinin antimalarials: mechanisms of action and resistance","volume":"58","author":"Meshnick","year":"1998","journal-title":"Med Trop revue du Corps de sante colonial"},{"issue":"6","key":"10.1016\/j.tube.2019.03.004_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tube.2019.03.004_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2125.1998.t01-1-00686.x","article-title":"Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria","volume":"45","author":"Sidhu","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.tube.2019.03.004_bib40","first-page":"3807","article-title":"Artemisinin-transferrin conjugate retards growth of breast tumors in the rat","volume":"29","author":"Lai","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tube.2019.03.004_bib41","doi-asserted-by":"crossref","first-page":"29461","DOI":"10.1038\/srep29461","article-title":"Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol\u2013dihydroartemisinin conjugate","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218304876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218304876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T23:05:01Z","timestamp":1554159901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979218304876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":41,"alternative-id":["S1472979218304876"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.03.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}